JFS Wealth Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10K Hold
99
﹤0.01% 1005
2026
Q1
$9.58K Buy
99
+4
+4% +$410 ﹤0.01% 967
2025
Q4
$10.1K Buy
95
+29
+44% +$3.36K ﹤0.01% 968
2025
Q3
$8.38K Hold
66
﹤0.01% 950
2025
Q2
$8.09K Sell
66
-4
-6% -$457 ﹤0.01% 933
2025
Q1
$7.09K Sell
70
-4
-5% -$391 ﹤0.01% 992
2024
Q4
$6.83K Buy
74
+4
+6% +$393 ﹤0.01% 994
2024
Q3
$6.76K Buy
70
+7
+11% +$629 ﹤0.01% 1002
2024
Q2
$5.41K Hold
63
﹤0.01% 1033
2024
Q1
$5.2K Hold
63
﹤0.01% 1083
2023
Q4
$4.2K Sell
63
-6
-9% -$389 ﹤0.01% 1131
2023
Q3
$4.63K Buy
69
+6
+10% +$413 ﹤0.01% 1014
2023
Q2
$4.27K Buy
63
+9
+17% +$564 ﹤0.01% 1073
2023
Q1
$2.92K Sell
54
-19
-26% -$1.11K ﹤0.01% 1214
2022
Q4
$4.37K Buy
73
+20
+38% +$1.09K ﹤0.01% 1049
2022
Q3
$2K Sell
53
-14
-21% -$700 ﹤0.01% 1308
2022
Q2
$3K Sell
67
-10
-13% -$513 ﹤0.01% 1171
2022
Q1
$4K Buy
77
+49
+175% +$2.56K ﹤0.01% 1129
2021
Q4
$1K Buy
+28
New +$1.44K ﹤0.01% 1331

Other funds holding EHC

JFS Wealth Advisors's EHC Position: Q2 2026 in Review

JFS Wealth Advisors held its Encompass Health (EHC) position steady in Q2 2026 at 99 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

JFS Wealth Advisors first reported a position in EHC in Q4 2021 and has held it in 19 quarters since. The position peaked at $10.1K in Q4 2025. 81 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • JFS Wealth Advisors held 99 shares of Encompass Health worth $10K as of Q2 2026.
  • JFS Wealth Advisors left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1005 holding.
  • JFS Wealth Advisors first reported a position in Encompass Health in Q4 2021 and has held it in 19 quarters since.
  • JFS Wealth Advisors's Encompass Health position peaked at $10.1K in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.